Intuitive Surgical Inc

ISRG: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$994.00BbbmZghxdxph

Intuitive's Next-Generation Platform Rollout Proceeding in Line With Expectations

Business Strategy and Outlook

Intuitive Surgical continues to benefit from the ongoing global adoption of robotic surgery, even in the procedures we didn't view as likely to convert. Our long-term positive view about the company's competitive positioning is unchanged even as new competitors have finally arrived on the scene, and with the release of the next-generation platform early in 2024, Intuitive should maintain its dominance.

Sponsor Center